MedTrace Logo

High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up

NCT03087409 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 885

Last updated 2024-05-03

No results posted yet for this study

Summary

Collection of follow-up data from the original trial patient cohort.

Conditions

  • Breast Cancer Female

Sponsors & Collaborators

  • The Netherlands Cancer Institute

    collaborator OTHER

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • J A Gietema, MD, PhD · University Medical Center Groningen

  • G Sonke, MD, PhD · The Netherlands Cancer Institute

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-07-01
Completion
2018-07-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03087409 on ClinicalTrials.gov